News - darapladib, Pharmaceutical

Filter

Current filters:

darapladibPharmaceutical

Popular Filters

ACC 2014: GSK’s darapladib disappoints in Ph III trial

ACC 2014: GSK’s darapladib disappoints in Ph III trial

31-03-2014

UK pharma major GlaxoSmithKline (LSE: GSK) presented disappointing data from its pivotal Phase III STABILITY…

Cardio-vasculardarapladibGlaxoSmithKlinePharmaceuticalResearchUKUSA

GlaxoSmithKline’s darapladib flops in Ph III CHD trial

GlaxoSmithKline’s darapladib flops in Ph III CHD trial

12-11-2013

UK pharma giant GlaxoSmithKline saw its shares dip 1.3% to £16.29 in mid-morning trading, after the…

Cardio-vasculardarapladibGlaxoSmithKlinePharmaceuticalResearch

Analysts recommend GSK after Teva announces Advair generic delay

Analysts recommend GSK after Teva announces Advair generic delay

11-10-2013

The delay for the generic version of GlaxoSmithKline’s Advair coupled with the advances in the company’s…

AdvairdarapladibEuropeFinancialGlaxoSmithKlineNeurologicalPharmaceuticalRespiratory and PulmonaryTeva Pharmaceutical Industries

Great expectations for GlaxoSmithKline R&D newsflow

13-12-2012

Essentially, analysts at Panmure Gordon & Co anticipate a lot of pipeline newsflow from UK pharma giant…

AdvairdarapladibFinancialGlaxoSmithKlineMAGE-A3PharmaceuticalResearch

Back to top